9^th International Virology Congress and Expo March 13-14, 2017 London, UK

The global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast periods to reach $14.1 billion in 2016.

Viral entry is the earliest stage of infection in the viral life cycle, as the virus comes into contact with the host cell and introduces viral material into the cell. The human immunodeficiency virus is a lentivirus(s subgroup of viruses) that causes HIV infection and acquired immunodeficiency syndrome. HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to look at new ways to prevent, detect, or treat HIV/AIDS. Clinical Trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

Viral diseases/infections of the oral cavity, oral mucosa and perioral regions are generally encountered by dentists and have not received the required recognition until recently and viruses are both - ulcer genic and the tumorigenic agents of human oral cavity. The plethora of mammalian viruses in the lesions seen in periodontitis proposes that viruses play a significant role in oral diseases than earlier recognized. One of the most crucial target of oral microbiology in future would be to arbitrate the diversity, magnitude, frequency, pathogenicity, treatment and prognosis of oral viruses and the infections they cause.

Zika virus is a member of the virus family Flaviviridae and the genus Flavivirus. It is spread by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. While there is no specific treatment, paracetamol (acetaminophen) and rest may help with the symptoms.As of 2016, the illness cannot be prevented by medications or vaccines. Zika can also spread from a pregnant woman to her foetus. This can result in microcephaly, severe brain malformations, and other birth defects.  Zika infections in adults may rarely result in Guillain–Barré syndrome.

Ebola virus disease (EVD), also known as Ebola haemorrhagic fever (EHF) or simply Ebola, is a viral haemorrhagic fever of humans and other primates caused by Ebola viruses. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches. Then, vomiting, diarrhoea and rash usually follow, along with decreased function of the liver and kidneys. At this time some people begin to bleed both internally and externally.

Due to the widespread infection of HCV and demand for these improved therapies, multiple estimates forecast the global market for HCV treatment will reach $20 billion annually by the end of the decade. 

The agricultural inoculants market, in terms of value, is projected to reach $398.56 million by 2019, at a CAGR of around 9.5% from 2014.

The epidemiology of plant virus diseases concerns the cyclical development of virus diseases within plant populations in time and space. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects a wide range of plants, especially tobacco and other members of the family Solanaceae. Mycology is the branch of biology which deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and their use to humans as a source for tinder, medicine, wine and entheogens, as well as their dangers, such as poisoning or infection.

"Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019", states that the global clinical trial management systems market, which was worth US$844 million in 2013, will grow at a CAGR of 14% between 2013 and 2019 to acquire net worth of an estimated US$1,848.5 million by 2019.

Clinical virology is a branch of medicine which comprises in disconnecting and/or in portraying one or a few infections in charge of some human pathologies by different immediate or backhanded methods (cell Cultures, serologies, biochemistry, molecular biology). It additionally comprises in demonstrating the nonattendance of resistance of viruses in treatment antiviral by viral genome sequencing to adjust antiviral therapeutics, best case scenario. Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system.

EAC predicts that the viral market will grow from its 2011 global size of $4.2 billion to $6.9 billion in 2016, representing a compound annual growth rate (CAGR) of 10.6%

 Viral infections are probably the most important cause of childhood morbidity and mortality in the world. In many developing countries in South East Asia and the Western Pacific, priority health problems include acute respiratory infections, acute diarrhoeas and arboviral infections. 

The Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

Antiviral drugs are a class of medication used specifically for treating viral infections. DNA immunization is a novel technique used to efficiently stimulate humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or attenuated viruses. Oncolytic virotherapy is an emerging treatment modality which uses replication competent viruses to destroy cancers. 

The global Cancer/Tumour Profiling Market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018.

Viral Gastroenteritis is an inflammation of the stomach and intestines caused by one of any number of viruses. It is also known as the stomach flu. Hepatocellular carcinoma is the most common type of liver cancer. Human Papillomaviruses (HPVs) are the causative agents of a number of human tumours, including cervical cancer, which is the major cause of cancer related death in women in many parts of the developing world.

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

Immunotherapy can be defined as the Treatment to stimulate or restore the ability of the immune (defence) system to fight infection and disease. Biological therapy is thus any form of treatment that uses the body's natural abilities that constitute the immune system to fight infection and disease or to protect the body from some of the side effects of treatment. Chemotherapy and radiation therapy are two of the most effective treatment approaches for cancer. 

The global animal healthcare market was valued at USD 27,861.2 million in 2013 and is expected to grow at a CAGR of 7.1% from 2014 to 2019, to reach an estimated value of USD 41,929.1 million in 2019.

Veterinary virology is the study of viruses in animals. It is an important branch of veterinary medicine. An Emerging virus is a term applied to a newly discovered virus, one that is increasing in incidence or with the potential to increase in incidence. Zoonotic diseases/infections are those which can be naturally transmissible from vertebrate animals to humans. Transmissible spongiform encephalopathies (TSEs), also known as prion diseases represent a group of conditions that affect the nervous system in humans and animals.

he vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%.

Major point driving growth of vaccine technology market incorporate rising pervasiveness of infections, increasing government activities for growing immunization over the globe, expanding organization interests in immunization improvement, and rising activities by non-government associations for immunizations. Clinical trials are research studies that investigate whether a medicinal methodology, treatment, or device is safe and effective for humans.

Relevant Conferences:

2nd World Congress on Infectious Diseases August 25-27, 2016 Philadelphia, USA; International Infectious Diseases & Diagnostic Microbiology Conference , October3-5, 2016; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia;4th International conference on Clinical Microbiology & Microbial Genomics, Oct 05-07, Philadelphia, USA; 32nd Clinical VirologySymposium,May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016 Argentina;10th Asia-Pacific Congress of Medical Virology,Oct 15-18,2016 Taiwan; 26th Annual Meeting of the Society for Virology,April 6-9,2016 Germany; 14th International Symposium onNeuroVirology,2016, Canada. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV), Swedish Society of Medical Microbiology.

The global market for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% between 2012 and 2017. A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.

The global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

Stem cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem cell therapy, but some therapies derived from umbilical cord blood are also in use.